Serum markers as predictors of immune checkpoint inhibitors (ICI) related adverse events in a real-world scenario

被引：0
|
作者：
Iacono, D. [1 ]
Vitale, M. G. [2 ]
Cortiula, F. [2 ]
Cinausero, M. [2 ]
Tullio, A. [3 ]
Valent, F. [3 ]
Macerelli, M. [1 ]
Follador, A. [1 ]
Vogrig, A. [4 ]
Minisini, A. M. [1 ]
Puglisi, F. [2 ]
Fasola, G. [1 ]
机构：
[1] ASUIUD Santa Maria Misericordia, Dept Oncol, Udine, Italy
[2] Univ Udine, Dept Med DAME, Udine, Italy
[3] ASUIUD Santa Maria Misericordia, Hyg & Clin Epidemiol Unit, Udine, Italy
[4] ASUIUD Santa Maria Misericordia, Dept Neurosci, Udine, Italy
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1198P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance
    Raschi, Emanuel
    Gatti, Milo
    Gelsomino, Francesco
    Ardizzoni, Andrea
    Poluzzi, Elisabetta
    De Ponti, Fabrizio
    TARGETED ONCOLOGY, 2020, 15 (04) : 449 - 466
  • [22] Real-world experience and outcomes of immune-checkpoint inhibitors (ICI) in hepatocellular carcinoma (HCC)
    Paul, Samuel
    Min, Eric
    Benson, Katherine K.
    Xu, Menglin
    Noonan, Anne M.
    Mittra, Arjun
    Malalur, Pannaga G.
    Roychowdhury, Sameek
    Jin, Ning
    Hays, John L.
    Elkhatib, Rifat T.
    Rahman, Shafia
    Miller, Eric David
    Pardo, Dayssy Alexandra Diaz
    Manne, Ashish
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [23] A real-world experience of immune checkpoint inhibitors (ICI) in metastatic renal cell carcinoma (mRCC)
    Elias, Roy
    Levonyak, Nicholas
    Christie, Alana
    Bowman, Isaac Alexander
    Kapur, Payal
    Hannan, Raquibul
    Hammers, Hans J.
    Brugarolas, James
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [24] Immune-related adverse events of checkpoint inhibitors
    不详
    Nature Reviews Disease Primers, 6 (1) : 39
  • [25] Immune-related adverse events of checkpoint inhibitors
    Ramos-Casals, Manuel
    Brahmer, Julie R.
    Callahan, Margaret K.
    Flores-Chavez, Alejandro
    Keegan, Niamh
    Khamashta, Munther A.
    Lambotte, Olivier
    Marlette, Xavier
    Prat, Aleix
    Suarez-Almazor, Maria E.
    NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01)
  • [26] Checkpoint inhibitors and gastrointestinal immune related adverse events
    Pernot, Simon
    Ramtohul, Toulsie
    Taieb, Julien
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (04) : 264 - 268
  • [27] Immune-related adverse events of checkpoint inhibitors
    Manuel Ramos-Casals
    Julie R. Brahmer
    Margaret K. Callahan
    Alejandra Flores-Chávez
    Niamh Keegan
    Munther A. Khamashta
    Olivier Lambotte
    Xavier Mariette
    Aleix Prat
    Maria E. Suárez-Almazor
    Nature Reviews Disease Primers, 6
  • [28] Real-world incidences and risk factors of immune-related adverse events in patients treated with immune checkpoint inhibitors: A nationwide retrospective cohort study
    Kim, Yong Joon
    Lee, Myeongjee
    Kim, Eun Hwa
    Lee, Seulkee
    Park, Sejung
    Shin, Sang Joon
    Jung, Inkyung
    Lee, Choong-kun
    CANCER LETTERS, 2024, 596
  • [29] REAL WORLD DATA OF SEQUENCING IMMUNE CHECKPOINT INHIBITORS (ICI) AFTER INITIAL ICI
    Gunturu, Krishna
    Awidi, Muhammad
    Ranjit, Rojer
    Connell, Brendan
    Carrasquillo, Rachel
    Gil, Brigitte
    Dalbo, Natalie
    Maher, Lewena
    Reilly, Seanna
    McDonald, Stephanie
    Tsoukas, Philip
    Voner, Linda
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A174 - A174
  • [30] Predictors for the development of neurological immune-related adverse events of immune checkpoint inhibitors and impact on mortality
    Yan, Chen
    Huang, Merry
    Swetlik, Carol
    Toljan, Karlo
    Mahadeen, Ahmad z. Z.
    Bena, James
    Kunchok, Amy
    Funchain, Pauline
    McGinley, Marisa
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (10) : 3221 - 3227
12345